Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

F. Locatelli; M.E. Bernardo; A. Bertaina; C. Rognoni; P. Comoli; A. Rovelli; A. Pession; F. Fagioli; C. Favre; E. Lanino; G. Giorgiani; P. Merli; D. Pagliara; A. Prete; M. Zecca

doi:10.1016/S1470-2045(17)30417-5

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

F. Locatelli, M.E. Bernardo, A. Bertaina, C. Rognoni, P. Comoli, A. Rovelli, A. Pession, F. Fagioli, C. Favre, E. Lanino, G. Giorgiani, P. Merli, D. Pagliara, A. Prete, M. Zecca

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1126-1136
Number of pages	11
Journal	The Lancet Oncology
Volume	18
Issue number	8
DOIs	https://doi.org/10.1016/S1470-2045(17)30417-5
Publication status	Published - 2017

Access to Document

10.1016/S1470-2045(17)30417-5

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85022028724&doi=10.1016%2fS1470-2045%2817%2930417-5&partnerID=40&md5=6c05644f987e2990168f7ad846ce1dcb

Cite this

Locatelli, F., Bernardo, M. E., Bertaina, A., Rognoni, C., Comoli, P., Rovelli, A., Pession, A., Fagioli, F., Favre, C., Lanino, E., Giorgiani, G., Merli, P., Pagliara, D., Prete, A., & Zecca, M. (2017). Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology, 18(8), 1126-1136. https://doi.org/10.1016/S1470-2045(17)30417-5

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. / Locatelli, F.; Bernardo, M.E.; Bertaina, A.; Rognoni, C.; Comoli, P.; Rovelli, A.; Pession, A.; Fagioli, F.; Favre, C.; Lanino, E.; Giorgiani, G.; Merli, P.; Pagliara, D.; Prete, A.; Zecca, M.

In: The Lancet Oncology, Vol. 18, No. 8, 2017, p. 1126-1136.

Research output: Contribution to journal › Article › peer-review

Locatelli, F, Bernardo, ME, Bertaina, A, Rognoni, C, Comoli, P, Rovelli, A, Pession, A, Fagioli, F, Favre, C, Lanino, E, Giorgiani, G, Merli, P, Pagliara, D, Prete, A & Zecca, M 2017, 'Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial', The Lancet Oncology, vol. 18, no. 8, pp. 1126-1136. https://doi.org/10.1016/S1470-2045(17)30417-5

Locatelli F, Bernardo ME, Bertaina A, Rognoni C, Comoli P, Rovelli A et al. Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology. 2017;18(8):1126-1136. https://doi.org/10.1016/S1470-2045(17)30417-5

Locatelli, F. ; Bernardo, M.E. ; Bertaina, A. ; Rognoni, C. ; Comoli, P. ; Rovelli, A. ; Pession, A. ; Fagioli, F. ; Favre, C. ; Lanino, E. ; Giorgiani, G. ; Merli, P. ; Pagliara, D. ; Prete, A. ; Zecca, M. / Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. In: The Lancet Oncology. 2017 ; Vol. 18, No. 8. pp. 1126-1136.

@article{46d13e0362984813bb2d3165d71a861a,

title = "Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial",

author = "F. Locatelli and M.E. Bernardo and A. Bertaina and C. Rognoni and P. Comoli and A. Rovelli and A. Pession and F. Fagioli and C. Favre and E. Lanino and G. Giorgiani and P. Merli and D. Pagliara and A. Prete and M. Zecca",

note = "Cited By :4 Export Date: 12 February 2018",

year = "2017",

doi = "10.1016/S1470-2045(17)30417-5",

language = "English",

volume = "18",

pages = "1126--1136",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

AU - Locatelli, F.

AU - Bernardo, M.E.

AU - Bertaina, A.

AU - Rognoni, C.

AU - Comoli, P.

AU - Rovelli, A.

AU - Pession, A.

AU - Fagioli, F.

AU - Favre, C.

AU - Lanino, E.

AU - Giorgiani, G.

AU - Merli, P.

AU - Pagliara, D.

AU - Prete, A.

AU - Zecca, M.

N1 - Cited By :4 Export Date: 12 February 2018

PY - 2017

Y1 - 2017

U2 - 10.1016/S1470-2045(17)30417-5

DO - 10.1016/S1470-2045(17)30417-5

M3 - Article

VL - 18

SP - 1126

EP - 1136

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 8

ER -